Status:
UNKNOWN
Exercise Training at Ambulatory Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis Patients
Lead Sponsor:
Rabin Medical Center
Conditions:
Idiopathic Pulmonary Fibrosis
Eligibility:
All Genders
30-90 years
Phase:
NA
Brief Summary
* Idiopathic pulmonary fibrosis (IPF) is a chronic progressive, fibrosing parenchymal lung disease with unknown etiology. The prevalence of IPF is estimated between 2-29 cases per 100,000 in general p...
Eligibility Criteria
Inclusion
- IPF patients diagnosed essentially according to the American Thoracic and European Respiratory Societies (ATS-ERS) by clinical diagnostic criteria of:
- High-resolution computed tomography (HRCT) demonstrating a pattern of "confident" or "possible" IPF (b) Abnormal pulmonary physiology with evidence of restriction and/or impaired gas exchange (can exist during exercise alone)
- Exclusion of other known causes of restrictive lung disease (e.g.: connective tissue disease, environmental exposure,etc
Exclusion
- Patients with severe comorbid illnesses, unstable coronary artery disease, collagen vascular diseases and the need for high flow oxygen therapy (˃ 3-4 L\\min).
- History of syncope on exertion or any comorbidities which precluded exercise training (such as severe orthopaedic or neurological deficits or unstable cardiac disease).
- Patients were also excluded if they had participated in a pulmonary rehabilitation program in the past 12 months.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01499745
Start Date
January 1 2012
End Date
December 1 2013
Last Update
December 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pulmonary Institute, Rabin Medical Center, Beilinson Hospital
Petah Tikva, Israel